These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9560916)

  • 1. [Chlamydia trachomatis: should it be systematically be screened or treated? Literature review and cost/benefit estimation in France].
    Henry-Suchet J; Sluzhinska A; Serfaty D
    Contracept Fertil Sex; 1998 Feb; 26(2):151-8. PubMed ID: 9560916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydia trachomatis screening in family planning centers: a review of cost/benefit evaluations in different countries.
    Henry-Suchet J; Sluzhinska A; Serfaty D
    Eur J Contracept Reprod Health Care; 1996 Dec; 1(4):301-9. PubMed ID: 9678112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
    BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Postma MJ; Bakker A; Welte R; van Bergen JE; van den Hoek JA; de Jong-van den Berg LT; Jager JC
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2350-4. PubMed ID: 11129971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-based decision analysis for Chlamydia screening in California family planning clinics.
    Trachtenberg AI; Washington AE; Halldorson S
    Obstet Gynecol; 1988 Jan; 71(1):101-8. PubMed ID: 3122137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
    van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potentials of screening for Chlamydia trachomatis in Hungary: cost-benefit analysis].
    Nyári T; Mészáros G; Deák J; Nagy E; Kovács L
    Orv Hetil; 2000 Jul; 141(27):1511-6. PubMed ID: 10943109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
    Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chlamydia trachomatis infection in men and its association with gynecologic alterations in their sexual partners].
    Guerra-Infante FM; Tapia-Yáñez JR; López-Hurtado M; Flores-Medina S; Díaz-García FJ
    Rev Invest Clin; 2005; 57(3):406-14. PubMed ID: 16187700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
    Land JA; Van Bergen JE; Morré SA; Postma MJ
    Hum Reprod Update; 2010; 16(2):189-204. PubMed ID: 19828674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening male prisoners for Chlamydia trachomatis: impact on test positivity among women from their neighborhoods who were tested in family planning clinics.
    Peterman TA; Newman DR; Goldberg M; Anschuetz GL; Salmon M; Satterwhite CL; Berman SM
    Sex Transm Dis; 2009 Jul; 36(7):425-9. PubMed ID: 19525892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
    Blake DR; Gaydos CA; Quinn TC
    Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chlamydia trachomatis in pregnant women in the county of Vestsjaelland. Prevalence, prevention of perinatal transmission and cost-effectiveness of screening].
    Ottesen M; Sahl I; Herbstman MM; Friis HM; Philipsen T
    Ugeskr Laeger; 1996 Feb; 158(6):756-8. PubMed ID: 8638313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia trachomatis genital infections--United States, 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(9):193-8. PubMed ID: 9072679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal screening or prophylactic treatment for Chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective?
    Chen S; Li J; van den Hoek A
    Sex Transm Dis; 2007 Apr; 34(4):230-6. PubMed ID: 17414068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and efficiency of selective vs universal screening for chlamydial infection in sexually active young women.
    Sellors JW; Pickard L; Gafni A; Goldsmith CH; Jang D; Mahony JB; Chernesky MA
    Arch Intern Med; 1992 Sep; 152(9):1837-44. PubMed ID: 1520050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
    Gillespie P; O'Neill C; Adams E; Turner K; O'Donovan D; Brugha R; Vaughan D; O'Connell E; Cormican M; Balfe M; Coleman C; Fitzgerald M; Fleming C
    Sex Transm Infect; 2012 Apr; 88(3):222-8. PubMed ID: 22213681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for asymptomatic Chlamydia trachomatis infection: cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Habets PC
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):499-501. PubMed ID: 11268916
    [No Abstract]   [Full Text] [Related]  

  • 20. Sex and age correlates of Chlamydia prevalence in adolescents and adults entering correctional facilities, 2005: implications for screening policy.
    Joesoef MR; Weinstock HS; Kent CK; Chow JM; Boudov MR; Parvez FM; Cox T; Lincoln T; Miller JL; Sternberg M;
    Sex Transm Dis; 2009 Feb; 36(2 Suppl):S67-71. PubMed ID: 19125147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.